CPT® Code 80438

1. Indications

The Thyrotropin releasing hormone (TRH) stimulation panel is indicated for the evaluation of specific thyroid-related conditions. The following are the primary indications for performing this test:

• Hypothyroidism Diagnosis - The test is utilized to differentiate between primary hypothyroidism and secondary or tertiary hypothyroidism, which involves the pituitary or hypothalamic dysfunction.
• Assessment of Pituitary Function - It helps in assessing the pituitary gland's ability to respond to TRH, which is crucial for understanding the underlying causes of thyroid hormone deficiencies.
• Evaluation of Thyroid Hormone Regulation - The test aids in understanding the regulatory mechanisms of thyroid hormones in the body, particularly in cases where thyroid function tests yield inconclusive results.

2. Procedure

The procedure for the Thyrotropin releasing hormone (TRH) stimulation panel involves several critical steps to ensure accurate measurement of TSH levels. The following steps outline the process:

• Step 1: IV Line Insertion - An intravenous (IV) line is inserted to facilitate the administration of Protirelin (TRH) and to obtain blood samples. This step is essential for ensuring that the procedure can be conducted smoothly and efficiently.
• Step 2: Baseline Blood Sample Collection - A baseline blood sample is obtained from the IV line or through a separately reportable venipuncture. This sample is crucial for measuring the initial TSH levels before the administration of TRH.
• Step 3: Administration of Protirelin - Protirelin, at a dosage of 200 mcg, is administered via IV push. This step is vital as it stimulates the pituitary gland to release TSH in response to the TRH.
• Step 4: Additional Blood Sample Collections - Following the administration of TRH, additional blood samples are collected at 20 and 60 minutes to measure the TSH levels. These time points are critical for assessing the pituitary response to TRH stimulation.

3. Post-Procedure

After the completion of the TRH stimulation panel, patients may be monitored for any immediate reactions to the administration of Protirelin. It is important to ensure that the IV line is properly managed and that any potential side effects are addressed. The collected serum or plasma samples will be sent for analysis using a quantitative chemiluminescent immunoassay to determine the TSH levels. The results will provide valuable information regarding the functioning of the pituitary gland and the hypothalamus in relation to thyroid hormone regulation. Follow-up consultations may be necessary to discuss the results and any further diagnostic or therapeutic steps that may be required based on the findings.